EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A rare TMEM175 mutation drives Parkinson’s disease pathology by disrupting proton gating and lysosomal acidification

Xiaotong Yang, Ping Li, Man Lv, Lingyong Wang, Ruyi Shan, Zikai Jiang, Danzhen Chen, Fangqian Huang, Weijie Cai, Liding Zhao, Zuoyou Guo, Xinhui Chen und 8 weitere

Journal of Clinical Investigation · 02.11.2026 · 136 (21)

DOI: 10.1172/jci206733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.11.2026. Verfasst von Xiaotong Yang und 19 weiteren Autor:innen. Beteiligte Einrichtung: New Cornerstone Science Laboratory & Liangzhu Laboratory, the Second Affiliated Hospital & School of Basic Medical Sciences, Zhejiang University, Han…. Hauptthemen laut MEDLINE: Lysosomes, Parkinson Disease, Protons, Mutation. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project of China, New Cornerstone Science Foundation, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transmembrane protein 175 (TMEM175), implicated in Parkinson’s disease (PD) risk, has been variably proposed to function as a background K + “leak” channel or a proton-activated proton channel in lysosomes. Here, we identified the rare TMEM175 variant p.L275R in a patient with early onset PD. Electrophysiological analyses revealed that TMEM175-L275R mutant proteins retain normal lysosomal expression and K + “leak” activity, but specifically lose proton- and agonist-dependent activation gating. In skin fibroblasts isolated from the patient with PD harboring the monoallelic p.L275R mutation ( TMEM175 +/L275R ), and in derived induced pluripotent stem cells and induced dopaminergic neurons, lysosomal H + flux, acidification, and degradation were impaired. These lysosomal defects were corrected upon genome editing to produce the isogenic WT allele (+/+ Cor ), but appeared when the mutant allele was introduced onto a WT background (+/L275R Mut ). Pathological α-synuclein aggregation was facilitated in patient-derived (+/L275R) and mutation-introduced (+/L275R Mut ) neurons. Consistent with these genetic findings, pharmacological activation of TMEM175 with small-molecule agonists restored lysosomal functions and reduced α-synuclein aggregation in TMEM175 +/L275R neurons. In in-vivo studies, equivalent-site–mutation knock-in mice demonstrated synucleinopathy and PD-like motor phenotypes. Collectively, our work provides genetic and pharmacological evidence that severe loss-of-function mutations may contribute causally to the onset age and pathogenesis of PD and identifies lysosomal proton channels and transporters as potential therapeutic targets for PD intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesParkinson DiseaseProtonsMutationIon Channel GatingMutation, MissenseHumansAnimalsMiceMaleDopaminergic NeuronsFemaleFibroblastsInduced Pluripotent Stem CellsPotassium Channels

Stichwörter der Autor:innen

AgingCell biologyDevelopmentIon channelsLysosomesParkinson disease

Substanzen

TMEM175 protein, humanProtonsPotassium Channels

Autor:innen und Institutionen

  • New Cornerstone Science Laboratory & Liangzhu Laboratory, the Second Affiliated Hospital & School of Basic Medical Sciences, Zhejiang University, Hangzhou, China.
  • Department of Neurology, the Second Affiliated Hospital and.
  • Departments of Pharmacology and Pathology, Sir Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Biophysics, the School of Basic Medical Sciences, Zhejiang University, Hangzhou, China.
  • Zhejiang Key Laboratory of Pain Perception and Neuromodulation, Hangzhou, China.
  • Institute of Fundamental and Transdisciplinary Research & The State Key Laboratory of Brain-Machine Intelligence, Zhejiang University, Hangzhou, China.

Förderung

  • National Science and Technology Major Project of China
  • New Cornerstone Science Foundation
  • National Key R&D Program of China
  • National Science Foundation of China

Zitieren

APA

Yang, X., Li, P., Lv, M., Wang, L., Shan, R., Jiang, Z., Chen, D., Huang, F., Cai, W., Zhao, L., Guo, Z., Chen, X., Cen, Z., Wang, Y., Yang, W., Li, X., Luo, W., Yang, L., Hu, M., & Xu, H. (2026). A rare TMEM175 mutation drives Parkinson’s disease pathology by disrupting proton gating and lysosomal acidification. Journal of Clinical Investigation, 136(21). https://doi.org/10.1172/jci206733

Vancouver

Yang X, Li P, Lv M, Wang L, Shan R, Jiang Z, et al. A rare TMEM175 mutation drives Parkinson’s disease pathology by disrupting proton gating and lysosomal acidification. Journal of Clinical Investigation. 2026;136(21). doi:10.1172/jci206733

BibTeX
@article{Yang2026,
  author = {Yang, Xiaotong and Li, Ping and Lv, Man and Wang, Lingyong and Shan, Ruyi and Jiang, Zikai and Chen, Danzhen and Huang, Fangqian and Cai, Weijie and Zhao, Liding and Guo, Zuoyou and Chen, Xinhui and Cen, Zhidong and Wang, Yichang and Yang, Wei and Li, Xinran and Luo, Wei and Yang, Lin and Hu, Meiqin and Xu, Haoxing},
  title = {A rare TMEM175 mutation drives Parkinson’s disease pathology by disrupting proton gating and lysosomal acidification},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {21},
  doi = {10.1172/jci206733}
}
Kostenlos starten →